Nuwellis Inc vs Energy Select Sector SPDR Fund — how do they compare? Nuwellis Inc trades at $2.94 (market cap $1.09M), while Energy Select Sector SPDR Fund trades at $58.56. The key difference: Energy Select Sector SPDR Fund is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NUWE | XLE | |
|---|---|---|
Market Cap | $1.09M | — |
Sector | Technology | — |
52-Week High | $527.46 | $62.57 |
52-Week Low | $2.80 | $42.12 |
Enterprise Value | -$722.58K | — |
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $3.00, up 5.26% over 24 hours, following a recent 35:1 reverse stock split effective June 26, 2026. The stock shows a bearish technical signal with all moving averages indicating sell. Fundamentally, the company reported a net loss of $17.52M in 2025, with negative profit margins, though revenue grew to $8.27M. Recent news highlights expansion in pediatric care and a $6M public offering closed in June 2026.
Outlook remains challenging due to persistent losses and high cash burn, but strategic initiatives in pediatric cardiorenal care and new patents offer growth potential. Key risks include negative ROE, reliance on financing, and competitive pressures. Analyst consensus is split evenly between Buy and Hold, reflecting cautious optimism amid financial headwinds.
XLE trades at $57.96, up 0.49% today, with a bullish technical signal supported by moving averages but showing overbought RSI readings. The ETF maintains a low 0.08% expense ratio and focuses on S&P 500 energy giants. Recent news highlights XLE's competitive advantages in liquidity and cost structure compared to energy infrastructure ETFs.
Outlook remains positive given elevated oil prices and strong sector earnings growth expectations, though overbought conditions and geopolitical risks warrant caution. The ETF's concentration in major energy companies provides stable exposure to traditional energy sector performance.
Trailing returns across standard periods
Latest headlines on both assets
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as energy companies by the GICS®, including securities of companies from the following industries: oil, gas and consumable fuels; and energy equipment and services. It is non-diversified.
Read more on XLE →